<DOC>
<DOCNO>EP-0618190</DOCNO> 
<TEXT>
<INVENTION-TITLE>
9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31445	C07D20900	C07D20716	C07C23920	C07D48700	C07D23300	C07D24900	A61K31445	C07D33320	C07D22100	C07C31700	C07C23900	C07D26500	A61K3165	A61K3138	A61K315375	C07D21300	C07C23726	C07D27900	C07D29524	C07D52100	C07D24104	A61K314402	C07D29522	C07D21338	C07D52100	C07D24908	C07D23360	C07D26300	C07D27912	C07D207327	C07D26502	C07D23112	A61K315375	C07D21126	C07C27100	C07D45300	A61K31381	C07D23364	C07D29520	C07D29514	C07D45302	A61K3112	A61K314418	A61K315377	A61K31381	C07D29512	C07D29500	A61K31403	C07C32300	A61K31535	A61K3140	C07D26530	C07D48708	C07D26332	C07D295215	C07D33300	C07C23700	C07D23354	C07C31736	A61K31535	A61P3100	C07D23100	C07C27122	C07D21340	C07D20952	A61K3138	C07D21100	A61K3112	A61K31415	C07D20902	C07D26100	C07D29515	A61K31403	A61K3165	A61K3140	A61K31415	C07D20700	C07C23918	A61K314418	A61P3104	C07C32360	C07D24100	C07D22122	C07D26102	A61K314402	C07D20732	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	C07D	C07D	C07C	C07D	C07D	C07D	A61K	C07D	C07D	C07C	C07C	C07D	A61K	A61K	A61K	C07D	C07C	C07D	C07D	C07D	C07D	A61K	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	A61K	C07D	C07C	C07D	A61K	C07D	C07D	C07D	C07D	A61K	A61K	A61K	A61K	C07D	C07D	A61K	C07C	A61K	A61K	C07D	C07D	C07D	C07D	C07D	C07C	C07D	C07C	A61K	A61P	C07D	C07C	C07D	C07D	A61K	C07D	A61K	A61K	C07D	C07D	C07D	A61K	A61K	A61K	A61K	C07D	C07C	A61K	A61P	C07C	C07D	C07D	C07D	A61K	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	C07D209	C07D207	C07C239	C07D487	C07D233	C07D249	A61K31	C07D333	C07D221	C07C317	C07C239	C07D265	A61K31	A61K31	A61K31	C07D213	C07C237	C07D279	C07D295	C07D521	C07D241	A61K31	C07D295	C07D213	C07D521	C07D249	C07D233	C07D263	C07D279	C07D207	C07D265	C07D231	A61K31	C07D211	C07C271	C07D453	A61K31	C07D233	C07D295	C07D295	C07D453	A61K31	A61K31	A61K31	A61K31	C07D295	C07D295	A61K31	C07C323	A61K31	A61K31	C07D265	C07D487	C07D263	C07D295	C07D333	C07C237	C07D233	C07C317	A61K31	A61P31	C07D231	C07C271	C07D213	C07D209	A61K31	C07D211	A61K31	A61K31	C07D209	C07D261	C07D295	A61K31	A61K31	A61K31	A61K31	C07D207	C07C239	A61K31	A61P31	C07C323	C07D241	C07D221	C07D261	A61K31	C07D207	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention provides compounds of the 
formula: 


wherein R, R¹, R² and W are defined in the 
specification. These compounds are useful as 

antibiotic agents. 
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<DESCRIPTION>
The invention relates to novel [4S-(4α,4aα,
5α,5aα,6α,12aα)]-4-(dimethylamino)-6-(substituted)-9-[[(substituted
amino)substituted]amino]-1,4,4a,5,5a,-6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamides
herein after called
9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines,
which exhibit antibiotic
activity against a wide spectrum of organisms including
organisms which are resistant to tetracyclines and are
useful as antibiotic agents.The invention also relates to novel 9-[(haloacyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracycline
and novel 9-[(protected aminoacyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracycline
intermediates
useful for making the novel compounds of the
present invention and to novel methods for producing
the novel compounds and intermediate compounds.This invention is concerned with novel
9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines,
represented by formula I,
which have antibacterial activity; with methods of
treating infectious diseases in warm blooded animals
employing these new compounds; with pharmaceutical
preparations containing these compounds; with novel
intermediate compounds and processes for the production
of these compounds. More particularly, this invention 
is concerned with compounds of formula I which have
antibacterial activity against tetracycline resistant
strains as well as a high level of activity against
strains which are normally susceptible to
tetracyclines.
In formula I, 
R is selected from α-CH3;
R1 is selected from hydrogen; straight or branched
(C1-C4)alkyl group selected from methyl, ethyl, propyl
and butyl; straight or branched (C1-C4)alkyl group
optionally substituted with amino; (heterocyclo)methyl
group said heterocycle selected from imidazolyl and
3-indolyl; (C5-C6)cycloalkylmethyl group selected from
(cyclopentyl)methyl and (cyclohexyl) methyl;
(C2-C4)carboxamidoalkyl group selected from
carboxamidomethyl and carboxamidoethyl;
R2 is selected from hydrogen and (C1-C2)alkyl selected
from methyl and ethyl;
W is selected from amino; (C1-C8) straight or branched
alkyl monosubstituted amino group substitution selected
from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl,
1-methylpropyl, 2-methylpropyl, n-hexyl and n-octyl;
(C3-C6)cycloalkyl monosubstituted amino group
substitution selected from cyclopropyl, cyclopentyl and
cyclohexyl; [(C4-C5)cycloalkyl] (C1-C2) alkyl
monosubstituted amino group substitution selected from
(cyclopropyl)methyl and
</DESCRIPTION>
<CLAIMS>
A compound of the formula:


wherein:

R is α-CH
3
;
R
1
 is selected from hydrogen; straight or branched (C
1
-C
4
) alkyl group selected
from methyl, ethyl, propyl and butyl; straight or branched (C
1
-C
4
) alkyl group
optionally substituted with amino; (heterocyclo)methyl group said heterocycle

selected from imidazolyl and 3-indolyl; (C
5
-C
6
) cycloalkylmethyl group selected
from (cyclopentyl)methyl and (cyclohexyl) methyl; (C
2
-C
4
)carboxamidoalkyl
group selected from carboxamidomethyl and carboxamidoethyl;
R
2
 is selected from hydrogen and (C
1
-C
2
) alkyl selected from methyl and ethyl;
W is selected from amino; (C
1
-C
8
) straight or branched alkyl monosubstituted
amino group substitution selected from methyl, ethyl, n-propyl, 1-methylethyl, n-butyl,

1-methylpropyl, 2-methylpropyl, n-hexyl and n-octyl; (C
3
-C
6
) cycloalkyl
monosubstituted amino group substitution selected from cyclopropyl, cyclopentyl

and cyclohexyl,
[(C
4
-C
5
) cycloalkyl] (C
1
-C
4
) alkyl monosubstituted amino group substitution
selected from (cyclopropyl)methyl and (cyclopropyl)ethyl; (C
3
-C
4
) alkenyl
monosubstituted amino group substitution selected from allyl and 3-butenyl; (C
7
-C
10
) 
aralkylamino group selected from benzyl, 2-phenylethyl and 1-phenylethyl;

straight or branched symmetrical disubstituted (C
2
-C
4
) alkylamino group
substitution selected from dimethyl and diethyl; straight or branched

unsymmetrical disubstituted (C
3
) alkylamino group substitution selected from
methyl(ethyl);(C
2
-C
5
) azacycloalkyl group selected from pyrrolidinyl and
piperidinyl; 1-azaoxacycloalkyl group selected from morpholinyl; substituted 1-azaoxacyclo-

alkyl group selected from 2-(C
1
-C
3
)alkylmorpholinyl; [1,n]-diazacycloalkyl

and substituted [1,n]-diazacycloalkyl group selected from

piperazinyl, 2-(C
1
-C
3
)alkyl- piperazinyl, 4-(C
1
-C
3
)alkylpiperazinyl, and 2,5-diaza-5-methylbicyclo[2.2.1]hept-2-yl

and the diastereomers and enantiomers of said
[1,n]
-diazacycloalkyl and substituted [1,n]-diazacycloalkyl group; 1-azathiacycloalkyl

and substituted 1-azathiacycloalkyl group selected from
thiomorpholinyl and
2-(C
1
-C
3
)alkylthiomorpholinyl; N-azolyl group selected from 1-imidazolyl;
(heterocycle)methylamino group selected from 2- or 3-thienylmethylamino and

2-, 3- or 4-pyridylmethylamino; (C
1
-C
4
)alkoxycarbonylamino group substitution
selected from methoxycarbonylamino, ethoxycarbonylamino, and 1,1-dimethylethoxycarbonyl-

amino; or R
1
 and W taken together are -CH
2
CH
2
CH
2

NH-;
and the pharmacologically acceptable organic and inorganic salts or metal
complexes.
A compound of the formula: 


wherein:

Y is selected from (CH
2
)
n
X, n = 0-5, X is halogen selected from bromine,
chlorine, fluorine and iodine; alternatively, X is a protected amino selected from

trifluoroacetylamino, (C
1
-C
4
) alkoxycarbonylamino [selected from t-butoxycarbonylamino,
methoxycarbonylamino, ethoxycarbonylamino,

allyloxycarbonylamino and 1,1,1-trichloroethoxycarbonyl- amino],

(C
7
-C
14
) arylalkoxycarbonylamino selected from benzyloxycarbonylamino,
naphthylmethoxycarbonylamino, 9-fluorenylmethoxycarbonylamino, p-methoxybenzyloxy-

carbonylamino, and p-nitrobenzyloxycarbonylamino, (C
7
-C
23
)
arylalkylamino selected from benzylamine, p-methoxybenzylamine, p-nitrobenzylamine,

tritylamine and 4-methoxytritylamine;
R, R
1
 and R
2
 are as defined in Claim 1.
The compound according to Claim 1 wherein said inorganic salts
comprise: hydrochloric, hydrobromic, hydroiodic, phosphoric, nitric or sulfate;

said organic salts comprise: acetate, benzoate, citrate, cysteine or other amino
acid, fumarate, glycolate, maleate, succinate, tar
trate, alkylsulfonate or
arylsulfonate; and said metal complexes comprise: aluminum, calcium, iron,

magnesium, manganese and complex salts. 
; A compound according to Claim 1,

[4S-(4alpha,12aalpha)]-4-(dimethylamino)-1,4,4a,5,5a, 6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-

methyl-9-[[(dimethylamino)acetyl]amino]
-1,11-dioxo-
2-naphthacenecarboxamide;

[4S-(4alpha, 12aalpha)]-4-(dimethylamino)-9- [[(dimethylamino)acetyl]
amino]-1,4,4a,5,5a,6,11,12a-

octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
monohydrochloride;

[4S-(4alpha, 12aalpha)]-4-(dimethylamino)-1,4,4a,5,5a,-6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-

1,11-dioxo-9-[[(dimethylamino)acetyl]amino]
-2-naphthacenecarboxamide
dihydrochloride;

[7S-(7alpha,10aalpha)]-N-[9-(aminocarbonyl)-7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-1-pyrrolidineacetamide;

[7S-(7alpha,10aalpha)]-N-[9-(aminocarbonyl)-7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-1,6,8,

10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-naphthacenyl]-1-piperidineacetamide;

[4S-(4alpha,12aalpha)]-9-[[(butylamino)acetyl]
amino]- 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,

10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(dimethylamino)-9-[[(diethylamino)acetyl]
amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;
 
[4S-(4alpha,12aalpha)]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-
1,11-dioxo-9-[[(1,1-dimethylethylamino)acetyl]
amino]-

2-naphthacenecarboxamide;

[7S-(7alpha,10aalpha)]-N-[9-(aminocarbonyl)-7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-1,6,8,

10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-naphthacenyl]-1-morpholineacetamide;

[4S-(4alpha,12aalpha)]-4-(dimethylamino)-1,4,4a,5,5a,-6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-

1,11-dioxo-9-[[[(phenylmethyl)amino]acetyl]
amino]-2-

naphthacenecarboxamide
dihydrochloride;

[4S-(4alpha,12aalpha)]-4-(dimethylamino)-1,4,4a,5,5a,- 6,11,12a-octahydro-3,5,10,12,12a-pentabydroxy-6-methyl-1,11-dioxo-9-[[[(2-thienylmethyl)amino]
acetyl]amino]
-2-
naphthacenecarboxamide dihydrochloride;

[4S-(4alpha,12aalpha)]-4-(dimethylamino)-1,4,4a,5,5a,-6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-

9-[[[(2-methylpropyl)amino]acetyl]
amino]-1,11-dioxo-2-naphthacenecarboxamide

dihydrochloride;

[4S-(4alpha,12aalpha)]-4-(dimethylamino)-1,4,4a,5,5a,- 6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-9-[[[(2-pyridinylmethyl)amino]
acetyl]amino]
2-naphthacenecarboxamide
dihydrochloride;
 
[4S-(4alpha,12aalpha)]
-4-(dimethylamino)-9-[[(methylamino)acetyl]amino]
-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide

dihydrochloride;

[7S-(7alpha,10aalpha)]-N-[9-(aminocarbonyl)-7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-1,6,8,-

10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-naphtha-
cenyl]
-α-methyl-1-pyrrolidinecarboxamide;

[4S-(4alpha,12aalpha)]-9-[[[(cyclopropylmethyl)amino]
- acetyl]amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-
dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(dimethylamino)-9-[[(dimethylamino)acetyl]
amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide

sulfate;

[4S-(4alpha,12aalpha)]-4-(dimethylamino)-9-[[(dimethylamino)-1-oxopropyl]
amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide dihydrochloride;

[4S-(4alpha,12aalpha)]-4-(dimethylamino)-9-[[(dimethylamino)-1-oxopropyl]
amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-

2-naphthacenecarboxamide monohydrochloride;

[4S-(4alpha,12aalpha)]-4-(dimethylamino)-9-[[(dimethylamino)-1-oxopropyl]
amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-

2-naphthacenecarboxamide;
 
[4S-(4alpha, 12aalpha)]
-4-(dimethylamino)-9-[[(dimethylamino)acetyl]amino]
-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(dimethylamino)-9-[[(hexylamino)acetyl]
amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide dihydrochloride;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)-7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-

naphthacenyl]-5-methyl-2,5-diazabicyclo[2;2;1]
heptane- 2-acetamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,3a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-3-methyl-4-morpholineacetamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-naphthacenyl]-2-azabicyclo[2;2;1]
heptane-2-acetamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-naphthacenyl]-4-methyl-1-piperazinecarboxamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-4-hydroxy-1-piperazineacetamide;
 
[7S-(7alpha,10aalpha)]
-N-[9-(Aminocarbonyl)-7-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-10,12-dioxo-2-

naphthacenyl]-4-methoxy-a-methyl-1-piperazinecarboxamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-4-(aminomethyl)-α-methyl-1-piperidine- acetamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)-1,4,4a,5,5a,- 6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-

9-[[2-methyl-2-(methylamino)-1-oxopropyl]amino]
-1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)- 9-[[2-(dimethylamino)-2-methyl-1-oxopropyl]
amino]-

1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)-9-[[2-(dimethylamino)-3,3-dimethyl-1-oxobutyl]
amino]-

1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)- 9-[[2-(ethylamino)-2-methyl-1-oxobutyl]
amino]-

1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[(Aminoacetyl)amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-
naphthacenecarboxamide;
 
[4S-(4alpha, 12aalpha)]
-9-[(L-Prolinyl)amino]-4- (dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-

3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-
naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[(L-Leucyl)amino]
-4- (dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[(L-Tryptophanyl)amino]
-4- (dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[(L-Glutamyl)amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[(L-Glutaminyl)amino]
-4- (dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[(L-Lysyl)amino]
-4- (dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[[L-b-(Cyclohexyl)alanyl]
- amino]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-
dioxo-2-naphthacenecarboxamide;
 
[4S-(4alpha, 12aalpha)]
-9-[L-(N-Methylleucyl)amino]-4- (dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-

3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-
2-naphthacenecarboxamide.
A compound which is one of

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-9-[[(methoxyamino)acetyl]
amino]-

1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-9-[[[(phenylmethoxy)-amino]
acetyl]amino]
-2-naphthacenecarboxamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-4-ethyl-1H-pyrazole-1-acetamide;

[4S-(4alpha, 12aalpha)]-9-[[(Cyclobutylmethylamino)- acetyl]
amino]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-

octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-
1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[[(2-butenylamino)acetyl]
-amino]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-9-[[(hydroxyamino)acetyl]
amino]-

1,11-dioxo-2-naphthacenecarboxamide;
 
[4S-(4alpha,12aalpha)]
-4-(Dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-9-[[[methyl(phenylmethyl)amino]acetyl]
amino]-2-naphthacenecarboxamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-6-methyl-2-azabicyclo[2;2;2]octane-2- acetamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-3-methyl-1-piperazinecarboxamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-3-cyclopropyltetrahydro-4H-thiazine-4-acetamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-3-ethyl-1H-pyrrole-1-acetamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-9-[[(1H-imidazol-2-ylmethylamino)-acetyl]
amino]-1,11-dioxo-2-naphthacenecarboxamide;

[7S-(7alpha,10aalpha)]-N-[2-[[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,1 0a, 11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
amino]-2-oxoethyl]
alanine;
 
[7S-(7alpha,10aalpha)]
-N-[2-[[9-(Aminocarbonyl)-7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
amino]-2-oxoethyl]
carbamic acid 1,1- dimethylethyl ester;
[4S-(4alpha,12aalpha)]
-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-9-[[[[(2-methylcyclopropyl)oxy]-amino]
acetyl]amino]
-1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[[[(Bicyclo[2;2;2]
oct- 2-yloxy)amino]acetyl]
amino]-4-(dimethylamino)-

1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-

9-[[[(3-methyl-2-butenyl)amino]acetyl]
amino]-1,11-

dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)-1,4,4a,5,5a, 6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-

methyl-9-[[[[4-[(2-methyl-1-oxopropyl)amino]phenyl]
-
amino]
acetyl]amino]
-1,11-dioxo-2-naphthacenecarboxamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-3-ethyl-1-pyrrolidineacetamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-9-[[2-[[(1-methyl-1H-imidazol-2-yl)-methyl]
amino]-1-oxopropyl]
amino]-1,11-dioxo-2-naphthacenecarboxamide; 

[4S-(4alpha, 12aalpha)]-9-[[2-(Dicyclopropylamino)- 1-oxopropyl]
amino]-4-(dimethylamino)-1,4,4a,5,5a,6,-11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-

1,11-dioxo-2-naphthacenecarboxamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)-7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-tetrahydro-a,2-dimethyl-4H-1,4-thiazine-4-acetamide;

[7S-(7alpha, 10aalpha)]-[2-[[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
amino]-2-oxo-1-methylethyl]
carbamic acid 2-propenyl
ester;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-9-[[2-[[3-(methylsulfonyl)phenyl]
-
amino]
-1-oxopropyl]amino]
-1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)-1,4,4a,5,5a,- 6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-

9-[[2-[[(3-methylcyclobutyl)oxy]amino]
-1-oxobutyl]-

amino]-1,11-dioxo-2-naphthacenecarboxamide hydrobromide;

[4S-(4alpha, 12aalpha)]-9-[[2-[(1,1-dimethylethyl)- methylamino]
-1-oxobutyl]amino]
-4-(dimethylamino)-
1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-a-ethyl-4-methyl-2-isoxazolidineacetamide;
 
[7S-(7alpha,10aalpha)]
-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-
1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-

naphthacenyl]-a-ethyl-3-methyl-4H-1,2,4-triazole-4- acetamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)- 9-[[2-(dimethylamino)-3-hydroxy-1-oxopropyl]
amino]-

1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
-a-(hydroxymethyl)-4-methyl-1H-imidazole-1-acetamide;

[4S-(4alpha,12aalpha)]-9-[[2-(Diethylamino)- 3-mercapto-1-oxopropyl]
amino]-4-(dimethylamino)-

1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methy]-1,11-dioxo-2-naphthacenecarboxamide;

[7S-(7alpha,10aalpha)]-N-[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10-12-dioxo-2-
naphthacenyl]
-a-(mercaptomethyl)-1-piperazineacetamide;

[7S-(7alpha,10aalpha]-4-[[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
amino]-3-(hexylamino)-4-oxobutanoic acid;

[7S-(7alpha,10aalpha)]-4-[[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a-6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-naphthacenyl]amino]
tetrahydro-6-(hydroxymethyl)-
2H-1,2-isoxazine-2-propanoic

acid;
 
[7S-(7alpha,10aalpha)]
-4-[[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-
1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-

naphthacenyl]amino]
-3-[ethyl(phenylmethyl)amino]-4- oxobutanoic

acid;

[7S-(7alpha,10aalpha)]-5-[[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
amino]-4-(cyclopropylamino)-5-oxopentanoic acid;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)- 9-[[2-(dimethylamino)-2-phenylacetyl]
amino]-

1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1-11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[[(Butylamino)(4-hydroxy- phenyl)acetyl]
amino]-4-(dimethylamino)-1,4,4a,5,5a,-

6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-
1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)-9-[2-(dimethylamino)-2-(4-methoxy
phenyl)acetyl]-1,4,4a,5,5a,-6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-

1-11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)-9-[[2- (ethylmethylamino)-3-[4-(trifluoromethyl)phenyl]
-
acetyl]
amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,-12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-4-(Dimethylamino)- 9-[[[4-(dimethylamino)phenyl]
(2-propenylamino)acetyl]-

amino]-1,4,4a,5,5a,6,11,12a-octabydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;
 
[4S-(4alpha,12aalpha)]
-9-[(D-Phenylalanyl)amino]-4- (dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-

3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-
naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[(L-Phenylalanyl)amino]
-4- (dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[(L-Tyrosinyl)amino]
-4- (dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[(L-(N,N-Dimethylphenyl- alanyl)amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-
octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-

dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)-9-[(L-Aspartyl)amino]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide.
A compound according to Claim 2,

[4S-(4alpha,12aalpha)]-9-[(bromoacetyl)amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;

[4S-(4alpha,12aalpha)]-9-[(chloroacetyl)amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
monohydrochloride;
 
[4S-(4alpha,12aalpha)]
-9-[(bromoacetyl)amino]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacene-

carboxamide monohydrobromide;

[4S-(4alpha,12aalpha)]-9-[(bromoacetyl)amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacene-
carboxamide monosulfate;

[4S-(4alpha,12aalpha)]-9-[(2-bromo-1-oxopropyl)amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,
10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide

monohydrobromide;

[4S-(4alpha,12aalpha)]-9-[(2-Bromo-2-methyl- 1-oxopropyl)amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,-
12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-

1,11-dioxo-2-naphthacenecarboxamide hydrobromide;

[4S-(4alpha,12aalpha)]-9-[(2-Bromo-1-oxobutyl)amino]
- 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide hydrobromide;

[4S-(4alpha, 12aalpha)]-9-[(2-Bromo-1-oxopentyl)amino]
- 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide hydrobromide;

[4S-(4alpha,12aalpha)]-9-[(2-Bromo-2-methyl-1-oxobutyl)amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
hydrobromide;
A compound which is one of:
 
[4S-(4alpha, 12aalpha)]
-9-[(2-Bromo-3-hydroxy-1- oxopropyl)amino]-4-(dimethylamino)-1,4,4a,5,5a,6,11,-

12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-
1,11-dioxo-2-naphthacenecarboxamide hydrobromide;

[4S-(4alpha,12aalpha)]-9-[(2-Bromo-3-mercapto- 1-oxopropyl)amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
hydrobromide;

[7S-(7alpha,10aalpha)]-4-[[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
amino]-3-bromo-4-oxobutanoic acid hydrobromide;

[7S-(7alpha,10aalpha)]-5-[[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
amino]-4-bromo-5-oxopentanoic acid hydrobromide;

[4S-(4alpha,12aalpha)]-9-[(Bromophenylacetyl)amino]
- 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-
3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-

naphthacenecarboxamide hydrobromide;

[4S-(4alpha,12aalpha)]-9-[[Bromo(4-hydroxyphenyl)- acetyl]
amino]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-

octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-
1,11-dioxo-2-naphthacenecarboxamide hydrobromide;

[4S-(4alpha,12aalpha)]-9-[[Bromo(4-methoxyphenyl)- acetyl]
amino]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-

octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
hydrobromide;
 
[4S-(4alpha,12aalpha)]
-9-[[Bromo[4-(trifluoromethyl)-phenyl]acetyl]
amino]-4-(dimethylamino)-1,4,4a,5,5a,6,-

11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-
1,11-dioxo-2-naphthacenecarboxamide hydrobromide;

[4S-(4alpha,12aalpha)]-9-[[Bromo[4-(dimethylamino)-phenyl]
acetyl]amino]
-4-(dimethylamino)-1,4,4a,5,5a,6,-11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-
1,11-dioxo-2-naphthacenecarboxamide hydrobromide;

[7S-(7alpha,10aalpha)]-N-[2-[[9-(Aminocarbonyl)- 7-(dimethylamino)-5,5a,6,6a,7,10,10a,12-octahydro-

1,6,8,10a,11-pentahydroxy-5-methyl-10,12-dioxo-2-
naphthacenyl]
amino]-2-oxoethyl]
carbamic acid 1,1-dimethylethyl ester.
A method of producing a compound, or its organic and inorganic salt or
metal complex, of the formula:



according to Claim 1, which comprises reacting a 9-[(haloacyl)amido]-5-hydroxy-6-(substituted)-6-

deoxytetracycline, or its organic and inorganic salt or metal
complex, of the formula:


 
according to Claim 2, with a nucleophile of the formula WH, wherein W is as

defined in Claim 1, in a polar-aprotic solvent and in an inert atmosphere.
A method of producing a compound, or its organic and inorganic salt or
metal complex, of the formula:



according to Claim 2, which comprises reacting 9-amino-5-hydroxy-6-substituted-6-deoxytetracycline,
or its organic and inorganic salt or metal

complex, of the formula:


with a straight or branched haloacyl halide of the formula:

 
wherein Y, R, R
1
 and R
2
 are as defined in Claim 2 and Q is halogen selected from
bromine, chloride, iodine and fluorine, in an inert solvent in a polar-aprotic

solvent and in the presence of a base.
A method of producing a compound, or its organic and inorganic salt
or metal complex, of the formula:



according to Claim 1, which comprises reacting a 9-amino-5-hydroxy-6-substituted-6-deoxytetracycline,
or its organic and inorganic salt or metal

complex, of the formula:


with an acid chloride of the formula:

 
wherein R, R
1
, R
2
 and W are as defined in Claim 1 and X is halogen selected from
bromine, chlorine, iodine and fluorine, in an inert solvent in a polar-aprotic

solvent and in the presence of a base.
A pharmaceutical composition of matter comprising a
pharmacologically efective amount of a compound according to Claim 1 in

association with a pharmaceutically acceptable carrier.
A compound according to any one of claims 1, 3, 4 or 5 for use as a
medicament.
Use of a compound according to any one of claims 1, 3, 4 or 5 in the
manufacture of a medicament for the treatment of bacterial infections in warm-blooded

animals.
</CLAIMS>
</TEXT>
</DOC>
